Duration: (2:55) ?Subscribe5835 2025-02-12T04:30:17+00:00
Inclisiran The First SiRNA Therapeutic
(7:1econd)
What is siRNA Technology?
(1:51)
Innovative siRNA Drug Delivery Systems
(2:29)
RNAi Therapeutics - How this New Class of Medicines Works
(2:56)
Lipid Nanoparticle Delivery Technology for siRNA and mRNA Therapeutics
(30:13)
siRNA therapeutics: next story for PCSK9?
(2:55)
Designing siRNAs for improving their therapeutic applications
(1:12:31)
Anastasia Khvorova: RNAi-based Therapeutics: 2018 Outlook
(59:20)
QB3 Webinar: Vasant Jadhav, Alnylam. \
(54:33)
Genetic Knock-Down (e.g. with RNAi - siRNA or shRNA) \u0026 Knock-Out (e.g. with CRISPR/Cas)
(28:55)
RNA interference (RNAi) Animated | miRNA | siRNA | mRNA regulation | gene silencing | PTGS | RISC
(10:7)
RNAi: Gene Regulation via miRNAs \u0026 siRNAs
(11:19)
An Introduction to siRNA - The Gene Silencing Ninja!
(4:17)
What is Antisense Technology? How Antisense RNA work? Application
(3:45)
RNA Interference I RNAi I siRNA I Small Interfering RNA I Post Transcriptional Mechanism
(9:33)
Difference between miRNA and siRNA. miRNA vs siRNA
(5:5)
siRNA | Short interfering RNA mechanism of RNA interference
(16:49)
ncRNAs - all types of non-coding RNA (lncRNA, tRNA, rRNA, snRNA, snoRNA, siRNA, miRNA, piRNA)
(5:43)
ASOs - AntiSense Oligonucleotides: what they are and how they work
(24:46)
Porous Silicon Microparticles For Delivery Of siRNA Therapeutics l Protocol Preview
(2:1econd)
Multistage Delivery of siRNA Therapeutics
(16:1econd)
What is an RNAi Therapeutic?
(55)
Quantification Methods for oligonucleotide therapeutics in serum and tissue
(35:)
Advancing siRNA Therapeutics with Nanoparticle Delivery
(26:41)
Roquefort Therapeutics STAT-6 siRNA Shows Efficacy in Experimental Model, Pursues Out-Licensing Deal
(4:34)
RNA interference (RNAi) Animation || miRNA || siRNA || mRNA regulation
(7:31)
How do RNAi Therapeutics Treat Disease?
(1:2)
Oligo Meeting 2017 - Target Knock Down - ASOs and siRNA
(17:38)
SiRNA therapeutics - A versatile technology platform for rare diseases
(1:24)
Progress Update: siRNA Based Compounds to Treat MECP2 Duplication Syndrome
(55:47)